Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, Plecha D, Madabhushi A. · 2017
Read Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. by Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, Plecha D, Madabhushi A. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5437672.txt.
Description
Braman and co-authors predict breast cancer chemotherapy response from MRI texture before treatment starts. Their study appeared in Breast Cancer Research. Neoadjuvant chemotherapy shrinks tumors before surgery. A complete response forecasts a good outcome. Only a minority of patients achieve one. The team mined scans for predictive patterns. They analyzed tumor tissue and the rim around it. Ninety-nine texture features came from contrast MRI.
The study covered 117 patients retrospectively. A training set of 78 built the models. An independent set of 39 tested them. Combined inside-plus-rim features reached an AUC of 0.74 on the independent test set. Splitting by receptor status improved matters. One subgroup peaked at 0.83 in its test results. The triple-negative and HER2-positive group peaked at 0.93 in those same tests. Predictive textures differed between those groups. Nonresponse in one group meant messy rim enhancement. In the other it meant speckled rim patterns.
Catalog record
| CREATOR | Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, Plecha D, Madabhushi A. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |